Sorbitol kinase, process for producing the same, and substantially pure microorganism

This application is a 331 of PCT/JP95/01997 filed Sep. 29, 1995 and claims priority under 35 U.S.C. 119 of Japanese application Ser. No. 6/243539 filed Oct. 7, 1994 and 6/247,419 filed Oct. 13, 1994.
FIELD OF THE INVENTION
This invention relates to a sorbitol kinase, which has properties utilizing mainly ATP, but not substantially phosphoenolpyruvate, as the phosphate donor, having N-terminal amino acid sequence (SEQ ID NO: 10) of the formula ##STR2## with stability up to 60.degree. C. DNA expressing the said sorbitol kinase, a process for producing sorbitol kinase comprising sorbitol kinase producing microorganism belonging to genus Erwinia in a medium and isolating sorbitol kinase therefrom, a substantially pure microorganism which produces said sorbitol kinase and process for producing sorbitol kinase using the said substantially pure microorganism.
PRIOR ARTS
Sorbitol is a representative substance in polyol, and is generated from glucose by aldose reductase.
In diabetes mellitus, when hyperglycemic condition occurred and intracellular hypergeneration of sorbitol continues, sorbitol is accumulated excessively in the cells due to less extracellular difusion of sorbitol, then various failure will occurres caused by accumulation of sorbitol. Accordingly, exact determination of sorbitol is important to find out disease condition of patients with diabetes mellitus.
Sorbitol is known to exist, especially in the crystalline lens, nerves and erythrocytes. Assay of sorbitol has been attempted for various organs. An amount of sorbitol in the erythrocytes converted into whole blood is the levels of approximately 10 .mu.M-50 .mu.M even in the patients with diabetes mellitus. (J. Malone et al.: Red cell sorbitol: An indicator of diabetic control. Diabetes: 861-864, 1980) Accordingly, no precise determination could be made.
Assay methods of sorbitol were knwon including, for example, gas chromatography, HPLC and enzymatic method using sorbitol dehydrogenase. Among them, gas chromatography and HPLC methods for determination of sorbitol are quite complicated. Enzymatic method using sorbitol dehydrogenase is quite disadvantage due to low substrate specificity of sorbitol dehydrogenase for sorbitol and sorbitol could not be assayed precisely.
We have searched in the references an enzyme having activity for sorbitol, and found 2 types of enzyme; i.e. sorbitol kinase from silk worm eggs having optimum pH approx. 9.5 and utilizing ATP and phosphoenol pyruvate as a phosphate donor (T. Yaginuma and O. Yamashita, Comp. Biochem. Physiol. 98B(1), 135-141, 1991) and hexokinase, from bovine and human eye lens, having sorbitol activity which utilize ATP as a phosphate donor and utilizing substrates of sorbitol and glucose (S. Srivastava et al. Biochim. Biophys. Acta, 717(2), 210-214, 1982). ATP is utilized mainly as a phosphate donor. Application of sorbitol kinase for practical use by extracting from silk worm eggs and bovine and human eyes is almost impossible. Futhermore, superior heat stability of the enzyme is not disclosed in the prior references.
Sorbitol kinase from microorganisms origin of Aerobacter aerogenes (N. E. Kelker and R. L. Anderson, J. Bacteriol., 160-164, 1971) has known. However, optimum pH of 7.6 and phosphoenolpyruvate as a phosphate donor have only disclosed in the reference, and no description on superior heat stability.
PROBLEMS TO BE SOLVED BY THE INVENTION
Production of sorbitol kinase from the origin except for microorganisms is known to be trace amount which can only be measured by radioisotope, consequently substantial isolation of the enzyme is impossible and no practical use has known. Sorbitol kinase from microorganism origin has property for only utilize phosphoenolpyruvate as a phosphate donor and does not utilize ATP, consequently practical use for diagnostic enzyme is doubtful.
We have extensively made search sorbitol kinase of microorganism origin having superior substrate specificity for sorbitol with utilizing ATP as a phosphate donor, and found sorbitol kinase, which utilize ATP, but not substantially phosphoenolpyruvate, as the phosphate donor and is stable up to 60.degree. C., in a culture of Erwinia sp. SK-472-20 (FERM BP-4492).
Production capacity of sorbitol kinase from Erwinia sp. SK-472-20 is very small, accordingly excellent production method by recombinant DNA technology has been expected to develop.
If mass production of sorbitol kinase can be made by Erwinia sp. SK-472-20, a composition for simple quantitative analysis of sorbitol can be provided by combining with sorbitol-6-phosphate dehydrogenase produced, for example, by Comamonas sp. SY-77-1 FERM BP-4810.
We have tried to isolate sorbitol kinase gene of Erwinia sp. SK-472-20 and searched DNA sequence and amino acid sequence of sorbitol kinase from the other origins, however no reports have been find out. Namely amino acid sequences of sorbitol kinase depending on the producing organisms could not be estimated.
Under these circumstances, because of low productivity of sorbitol kinasefrom Erwinia sp. SK-472-20, which has high reactivity and stability and is effective for assay of sorbitol, development of microorganism, which produces the enzyme effectively, by genetic engineering technology has been highly expected. However, no reports on essential fundamental informations for genetic engineering production of sorbitol kinase consisting of primary structure of polypeptides and DNA sequences coding amino acid sequences of the said enzyme have known. Accordingly, determination of primary structure of polypeptides constructing sorbitol kinase, DNA sequence coding amino acid sequences of the said enzyme and production of the said enzyme by genetic engineering are essential.
The present invention has completed for the purposes to provide for developing microorganism which produce effectively sorbitol kinase useful for assay of sorbitol, mass production method of the said enzyme using the said microorganism and the said microorganism per se.
MEANS FOR SOLVING THE PROBLEMS
We have studied practically useful sorbitol kinase for diagnostic enzyme and process for production thereof, and found that a strain SK-472-20 of genus Erwinia isolated from a soil sample collected from the field in Hiroshima City produced sorbitol kinase. Futher we have found that the isolated sorbitol kinase utilized mainly ATP, but not substantially phosphoenolpyruvate, as a phosphate donor, and completed the present invention.
Further, we have studied to complete the above objects and screened gene DNA expressing sorbitol kinase from chromosomal DNA library of microorganism origin which produced the said enzyme, followed by constructing expression vector using the said DNA. The DNA was inserted into a microorganism, for example, belonging to Escherichia coli (hereinafter sometimes designates as E.coli) to produce transformant which was cultured in a medium, then we have found that the said sorbitol kinase was effectively produced in large quantity. The present invention has completed by the above findings.
An object of the present invention is to provide sorbitol kinase having the following biochemical properties.
(1) Enzyme action
Enzymatic action on sorbitol as a substrate is as follows. Utilizing mainly ATP but not phosphoenolpyruvate as a phosphate donor.
Sorbitol+ATP.fwdarw.sorbitol-6-phosphate+ADP
(2) Substrate specificity
Substrate specificity on sorbitol.
(3) N-terminal amino acid sequence
Containing the following sequence: ##STR3## (4) Heat stability
Stable at least up to 60.degree. C. when a 100 mM Tris-HCl buffer (pH 8.5, containing 0.5 U/ml of sorbitol kinase) is heated for 15 minutes at various temperatures and the residual activity is measured.
Another object of the present invention is to provide a process for production of sorbitol kinase comprising culturing sorbitol kinase producing microorganism belonging to genus Erwinia and isolating the sorbitol kinase from the cultured mass.
Further object of the present invention is to provide a polypeptide substantially coding amino acid sequence SEQ ID NO: 2 consisting of amino acid Nos. 1 to 313 (FIG. 9) shown in SEQ ID NO: 1 which showing novel sorbitol kinase utilizing ATP, but not substantially utilizing phosphoenolpyruvate, as a phosphate donor.
More further object of the present invention is to provide DNA having base sequence substantially coding amino acid sequence consisting of amino acid Nos. 1 to 313 shown in SEQ ID NO: 1.
Still further object of the present invention is to provide a process for production of sorbitol kinase comprising culturing sorbitol kinase producing substantially pure microorganism, which is the microorganism transformed by recombinant plasmid having base sequence substantially coding amino acid sequence consisting of amino acid Nos. 1 to 313 shown in SEQ ID NO: 1, and isolating sorbitol kinase from the cultured mass.
Still more further object of the present invention is to provide a microorganism transformed by recombinant plasmid having base sequence substantially coding amino acid sequence consisting of amino acid Nos. 1 to 313 shown in SEQ ID NO: 1.
The present invention is explained in details in the following.
The sorbitol kinase producing microorganism of the present invention is not limited if it has an ability to produce sorbitol kinase and belongs to genus Erwinia, including variants and mutants which produce sorbitol kinase. Preferable example of the microorganism is a strain SK-472-20 belonging to genus Erwinia.
Taxonomical properties of the strain are as follows.
Identification of the strain was made in accordance with Determinative Medical Bacteriology (2nd Ed.), Microbiological methods (Vol. 3). Results were refered to Determinative Medical Bacteriology (2nd Ed.), Bergey's Manual of Systematic Bacteriology, Vol. 1 and 2, Int. J. Syst. Bacteriology.
Specific Characters on Growth
Bouillon plate medium
Circular shape with round edges. Smooth surface with creamy--grayish white. Lustered. Opaque. No production of soluble pigment.
Buillon liquid medium
Good growth with uniform growth.
Litmus milk medium and BCP milk mediuim
Acidic with coagulation.
Morphological Characters
Bacillus with round edges, 0.59.times.1.38 .mu.m in size. Peritrichal movement (it could not clearly be observed by flagellar staining and electron microscope, but could be determined by motilities with changing direction and zigzag movement according to observation of bacterial motility in spreading growth in motility test and microscopic observation).
No polymorphism. No sporulation.
______________________________________Physiological and biochemical characters______________________________________Gram stain -Acid-fast stain -OF test (Hugh-Lefuson) FGOF test (nitrogen source: NH.sub.4 H.sub.2 PO.sub.4) FGAerobic growth +Anaerobic growth +Growth temperature:51.degree. C. -46.2.degree. C. +30.degree. C. + (optimum temp.)12.degree. C. +Halotolerance:0% +5% +7% +10% +Growth pH:3.43 -4.32 +7.0 + (optimum pH)9.91 +10.31 -Decomposition activitygelatin -casein -esculin +cellulose -tyrosine -arginine -starch (+)Enzyme productivitycatalase +oxidase -urease (SSR) -urease (Chris.) +L-lysine decarboxylase -L-ornithine decarboxylase +DNase -.beta.-glucuronidase -Productivityindol -H.sub.2 S (SIM medium) +H.sub.2 S (TSI medium) +MR test -VP test +Nitrate reduction +Nitrite reduction +Utilization in Simmons medium (alkaline formation)citrate +malate +maleinate -malonate +propionate -gluconate -succinate +Utilization in Christenssen mediium (alkalineformation)citrate +malate +maleinate -malonate +propionate -gluconate +succinate +Acid formation from sugaradonitol -L(+) arabinose +cellobiose +dulcitol -meso-erythritol -D-fructose +D-galactose +D-glucose +glycerin +inositol +inulin -lactose +maltose +D-mannitol +D-mannose +melezitose -melibiose +D-raffinose +L(+)-rhamnose +D-ribose +salicin +L(-)-sorbose +sorbitol +starch +saccharose +trehalose +D-xylose +Gas formation from sugarD-glucose +lactose +Utilization of inorganic nitrogen sourcesnitrate -ammonium salt +Deamination of phenylalanine -______________________________________
As shown in the above, major properties of the strain are summarized as follows. Gram negative bacillus with peritrichal motility. Catalase positive, oxidase negative and facultative anaerobe. Fermentative decomposition of glucosewith generation of acid and gas.
The strain belongs Enterobacteriaceae because of Gram positive facultative anaerobic bvacteria of oxidase nonproducer. Since many genera are known to belong Enterobacteriaceae, genus Erwinia and genus Enterobacter may be applicable to the strain. However, no genus Enterobacter is known to produce hydrogen sulfate in TSI medium, accordingly the strain is referred to genus Erwinia. In general, although genus Erwinia is non-production of gas and urease, however there may be some exceptions in genus Erwinia. Three exceptional species and the present strain are compared with each other.
Table shows comparison of following strains.
The present strain;
A: Erwinia chrysanthemi;
B: Erwinia cypripedii;
C: Erwinia nigrifluens.
______________________________________ The strain A B C______________________________________Motility + + + +Anaerobic growth + + + +H.sub.2 S production from cystein + + + +Acetoin production + + - +Urease production + - - +Production of gas from glucose + + + -Casein hydrolysis - d - -Gelatin hydrolysis - + - -Deamination of phenylalanine - - + -Indol production - + - -Nitrate reduction + + + -Growth in 5% NaCl + d + NDDNase production - - - -Decomposition of esculin + + + +Acid production from sugarsaccharose + - - -melibiose + + + +inositol + d + +raffinose + + - +malitose + - + -L(+) arabinose + + + +sorbitol + + + +ribose + + + +mannose + + + +mannitol + + + +cellobiose + + + -lactose + d - -rhamnose + + + +salicin + + + +xylose + + + +trehalose + - + +dulcitol - - - -glycerin + + d +adonitol - - - -melezitose - - - -starch + - - -______________________________________ +: positive, -: negative, d: different in strains, ND: no data.
As shown in the above, the present strain has no similar strain in comparison with the other strains. Accordingly, the present strain was referred as Erwinia sp. SK-472-20, and has been deposited in National Institute of Bioscience and Human-Technology, 1-3, Higashi 1 chome Tsukuba-shi Ibaraki-ken, 305 Japan on Dec. 10, 1993 as FERM BP-4492.
We have found that the strain genus Erwinia produced sorbitol kinase and examined purification and properties of the enzyme.
The strain used in the present invention is a sorbitol kinase producing strain such as Erwinia sp. SK-472-20.
In the present invention, liquid culture and solid culture can be applicable, however aeration culture may be preferable for industrial production. Cultivation media used for production can include common carbon sources, nitrogen sources, inorganic salts and other nutrient sources used in culture of microorganisms. Other assimilable nutrient sources for microorganisms genus Erwinia can be used.
Examples of carbon sources are glucose, fructose, saccharose, xylose, maltose, glycerol, dextrin, starch, amino acids, fatty acids, oil and organic acids, in combination or alone. Examples of nitrogen sources are inorganic or organic nitrogen. Examples of inorganic nutrients are ammonium sulfate, ammonium nitrate, urea, sodium nitrate and ammoniuim chloride. Examples of organic nitrogen sources are powder of soybean, rice, corn and wheat, corn steep liquor, peptone, meat extract, casein, amino acids and yeast extract. Examples of inorganic salt and trace nutrients are salt of phosphate, magnesium, potassium, iron, calcium or zinc. Other components, which can be used for bacterial growth and stimulate production of sorbitol kinase, such as vitamins, non-ionic surface active agents and untifoam agents can be used, if necessary.
Cultivation can be proceeded by aerobic conditions within cultivation temperature for growth of the bacteria and production of sorbitol kinase, generally at 15.degree.-37.degree. C., preferably at 25.degree. C.-35.degree. C. Culturing time depends on the condition and can be continued until the maximum production of sorbitol kinase, generally for 24-100 hours.
The thus produced sorbitol kinase accumulated generally in the cells, consequently it can be extracted from bacterial cells. Extraction of sorbitol kinase can be performed by separating the cells from cultured mass, suspending the obtained wet cells in phosphate buffer or Tris-HCl buffer solution and subjected to combination of treatments for microbial cells such as lysozyme treatment, ultrasonication, French-press and dynamil to obtain the crude sorbitol kinase solution.
Sorbitol kinase can be isolated by treatments of known isolation and purification methods for proteins and enzymes from the crude sorbitol kinase solution. For example, the crude sorbitol kinase solution was subjected to fractional precipitation using organic solvent such as acetone, methanol and ethanol, or salting out using ammonium sulfate or sodium chloride to precipitate and isolate sorbitol kinase. The precipitate is treated, if necessary, by dialysis and isoelectric precipitation, and is purified by electrophoresis and column chromatography using ion-exchanger, gel-filtration agents and adsorbents. If necessary, combination of these treatments can be applied for obtaining purified sorbitol kinase.
The thus obtained enzyme can be treated by ultrafiltration and lyophilization with or without adding salts, sugars, proteins, lipids and surface active agents to obtain liquid or solid sorbitol kinase. In the lyophilization, saccharose, mannitol, sodium chloride or albumin can be added in its amount of 0.5-10% as a stabilizer.
Physicochemical properties and assay method of sorbitol kinase are explained as follows.
Assay Method of Sorbitol Kinase
One milliliter of a reaction mixture consisting of 0.2M Tris-HCl buffer solution (pH 8.5) 0.2 ml, 0.1M ATP 0.02 ml, 0.1M MgCl.sub.2 0.02 ml, 100 U/ml sorbitol-6-phosphate dehydrogenase (refer to referential example) 0.05 ml, 10 mM NAD 0.1 ml, 100 U/ml diaphorase (Asahi Chemical Ind. Co.) 0.05 ml, 0.25% NTB 0.1 ml, 1M sorbitol 0.1 ml, 10% Triton X-100 0.01 ml and distilled water 0.3 ml was pre-heated at 37.degree. C. for 1 minute, and the enzyme solution 20 .mu.l was added thereto, then the mixture was incubated for 10 minutes.
Reaction was terminated by adding 0.1N HCl 2 ml and optical density of the mixture was measured using 1.0 cm cell at 550 nm within 5 minutes (As). Also optical density of distilled water 20 .mu.l in place of the enzyme solution was measured in the same manner as above as a blank test (Ab). Enzymatic activity is determined by difference in the absorption between the optical density of the enzyme solution (As) and the blank test (Ab), i.e. (As-Ab). A unit of enzyme activity is defined as an amount of enzyme which generate 1 .mu.m of reduced NAD in one minutes at 37.degree. C. and calculated by the following equation.
Enzyme activity (U/ml)=(As-AB).times.0.795.times.dilution rate of enzyme
Physicochemical Properties
(1) Enzyme action
Enzyme action using sorbitol as a substrate is illustrated as follows.
Sorbitol+ATP sorbitol-6-phosphate+ADP
(2) Substrate specificity
Substrate specificity for sorbitol is indicated. Substrate specificities on various substrates are shown in Table 1.
TABLE 1______________________________________Substrate Relative activity (%)______________________________________Sorbitol 100Glycerol 0Xylose 0Inositol 0Saccharose 0Mannitol 0Maltose 0Treharose 0Glucose 0Mannose 0Galactose 0Fructose 0Lactose 0N-acetylglucosamine 02-deoxyglucose 0Fructose-1-phosphate 0Glucose-6-phosphate 0Galactose-1-phosphate 0______________________________________
(3) Phosphate donor
Relateive activities for GTP, ITP and UTP, when activity for ATP (final concentration 2 mM) is set as 100%, are 11.8%, 40.5% and 3.6%, respectively, accordingly phosphate donor or the enzyme is ATP. No substantial utilization of phosphoenolpyruvate is observed when phosphoenolpyruvate is replaced by ATP for assaying enzyme activity.
(4) Isoelectric point
4.8.+-.0.5 (electrophoresis using carrier ampholytes)
(5) Molecular weight
50000.+-.5000 (gel-filtration using TSK-G3000SW.sub.XL)
35000.+-.5000 (SDS polyacrylamide electrophoresis)
(6) Optimum pH
Optimum pH is measured by the above enzyme assay method. Results are shown in FIG. 1. In FIG. 1, 100 mM phosphate buffer is used for pH 6.0-8.0 (-.largecircle.-); 100 mM Tris-HCl buffer for pH 7.0-9.0 (-.circle-solid.-); and 100 mM glycine-sodium hydroxide buffer for pH 9.0-10.5 (-.quadrature.-). Optimum pH is 8.5-9.5.
(7) pH stability
100 mM buffer solutions containing sorbitol kinase 0.5 U/ml were treated at 60.degree. C. for 15 minutes, and remaining activity was measured by the above enzyme assay method. Results are shown in FIG. 2. In FIG. 2, 100 mM acetate buffer is used for pH 4.5-6.0 (-.largecircle.-); 100 mM phosphate buffer for pH 6.0-8.0 (-.circle-solid.-); 100 mM Tris-HCl buffer for pH 7.0-8.5 (-.quadrature.-); and 100 mM glycine-sodium hydroxide buffer for pH 9.0-10.5 (-.box-solid.-). Most preferable stability is observed at pH 6.5-10.0.
(8) Optimum temperature
Optimum temperature of the enzyme was measured by changing temperature range at 37.degree. C.-60.degree. C. according to the above assay method. Result is shown in FIG. 3, in which optimum temperature of the present enzyme is approx. 50.degree. C.
(9) Heat stability
100 mM Tris-HCl buffer solution (pH 8.5) containing sorbitol kinase 0.5 U/ml was treated at various temperatures for 15 minutes, and remaining activity was measured by the above enzyme assay method. Results are shown in FIG. 4 in which the enzyme is stable at least up to 60.degree. C.
(10) Effects of metal ions and chemical modifiers on enzyme activity
Effect of various metal ions (2 mM) on the enzyme in the presence of 2 mM magnesium ion is shown in Table 2.
TABLE 2______________________________________Metal ion and Relative activitychemical modifier (%)______________________________________None 100LiCl 74.3NaCl 112KCl 180CsCl 85CuCl.sub.2 0NiCl.sub.2 14.5CoCl.sub.2 17.3CaCl.sub.2 44.6EDTA 0NaN.sub.3 123______________________________________
As shown in the Table 2, the enzyme of the present invention was inhibited by CuCl.sub.2, NiCl.sub.2, CoCl.sub.2 and EDTA, and was activated by KCl.
(11) N-terminal amino acid sequence
N-terminal amino acid sequence of the enzyme is as follows. ##STR4##
As explained in the above, sorbitol kinase of the present invention utilizes mainly ATP, but not phosphoenolpyruvate, as a phosphate donor and is stable at least up to 60.degree. C., consequently it is different from sorbitol kinase of Aerobacter aerogenes. Further the enzyme activated by KCl, consequently it is different from known sorbitol kinase.
Genetic manipulation in relation to the enzyme of the present invention is explained in details.
In the present invention, sorbitol kinase expressing gene DNA used for preparing transformed microorganism which produces sorbitol kinase can be obtained, for example, by screening from chromosomal DNA library originated from the said enzyme producing microorganism.
Erwinia sp. SK-472-20 is preferably used for production of sorbitol kinase of the present invention. Methods for screening the enzyme expressing gene DNA from chromosomal DNA library of Erwinia sp. SK-472-20 is exemplified. At first, chromosomal DNA of the said microorganism at about 100-2000 .mu.g is extracted by conventional method.
Plasmid, to which sorbitol kinase coding gene DNA is inserted, is constructed. Vector for preparation of library is preferably constructed for genetic recombinant from autonomously growing phage or plasmid in the host cells. Examples of the above phage are .lambda.gt.multidot..lambda.C and .lambda.gt.multidot..lambda.B for host microorganims E.coli. Examples of plasmids for host microorganims E.coli are pBR322, pBR325, pACYC184, pUC12, pUC13, pUC18, pUC19, pUC118, pUC119, bluescript SK+, bluescript KS+, bluescript SK-, bluescript KS-, bluescript SKII+, bluescript KSII+, bluescript SKII- and bluescript KSII-. Examples of plasmids for host microorganims genus Bacillus and genus Saccharomyces are pHY300PLK and pYAC5, respectively.
Insertion method of sorbitol kinase gene into the vector is not limited, and conventional methods can be used. For example, the extracted chromosomal DNA 1-10 .mu.g of the said microorganism is treated by preferable restriction enzyme, as well as being treated the vector 1-10 .mu.g for preparation of library by preferable restriction enzyme. After annealing each cohesive end, the sequence is ligated by using preferable DNA ligase and transformed in the host microorganism to prepare chromosomal DNA library.
Examples of preferable host microorganism are E.coli. Insertion of the constructed plasmid into E.coli is preferably made by competent cell method or calcium phosphate method. Selection of gene transfer into the host microorganism can be made by culturing the said host microorganism in selective medium based on drug resistance marker of vector consisting of recombinant DNA to select growing host microorganism.
Meanwhile, N-terminal amino acid sequence of the authentic sorbitol kinase, i.e. amino acid sequence of lysyl endopeptidase treated fragments, is determined. Various oligonucleotides were synthesized based on the above sequence and isotope labelled oligonucleotides were prepared.
Recombinant E.coli having sorbitol kinase expressing gene is expected to be screened from the above chromosomal DNA library by the conventional method using the radio active oligonucleotide prove. However, the process of this screening is very difficult in the present invention, and the clones bearing sorbitol kinase gene could not be found out in spite of preparing various probes from partial amino acid sequence of sorbitol kinase.
In design of probe, the probe is synthesized by selecting generally estimated sequence of DNA sequence combination as little as possible. In sorbitol kinase of the present invention, sequence with less combination does not exist. Consequently, we have prepared the probes by narrowing the combination down from various combination with referring to use frequency of codon of Erwinia gene. Further, probes consisting of inosine in the multiple estimated parts were prepared. Length of the probes is also examined. Furthermore, hybridization and washing conditions (composition of solution, temperature and time) are examined. Finally, in the present invention, as explained in the examples hereinbelow, recombinant E.coli, which was selected by using radioactive oligonucleotide probes based on N-terminal amino acid sequence, being hybridized with specific condition and washing, is found to bear the desired gene DNA.
A recombinant plasmid (designated as pSK1) containing DNA with sorbitol kinase gene can be prepared from the recombinant library containing the said gene DNA according to a method of Maniatis et al. �Molecular Cloning: Cold Spring Harbor (1982)!. Schematic diagram of construction of the said plasmid is shown in FIG. 12. Restriction map of a part originated from chromosomal DNA of Erwinia sp. SK-472-20 in the said plasmid is shown in FIG. 11.
Base sequence of the part originated from chromosome in the plasmid in FIG. 12 was determined by dideoxy method �"Science" 214: 1205-1210, 1981!, and was confirmed to contain whole DNA coding sorbitol kinase, as well as determining the total base sequence. It contains at least a sequence shown in FIG. 10. Complete identification with the expression of sorbitol kinase of the present invention, N-terminal amino acid sequence of sorbitol kinase and the identical frame of amino acid sequence in lysylendopeptidase treated fragment could show that sorbitol kinase of the present invention contains amino acid seqeuence in FIG. 9.
In the sequences of FIG. 9 and FIG. 10, substantially similar sequence relating to sorbitol kinase activity is included in the present invention.
Expression of sorbitol kinase can preferably be made using pSK1. Alternatively, expression vector, to which sorbate kinase coding gene DNA is newly inserted, can be constructed. Preferable expression vector is a phage or plasmid constructed for genetic recombinant from autonomously growing phage or plasmid in the host microorganism. Examples of the former phage are, for example, .lambda.gt.multidot..lambda.C and .lambda.gt.multidot..lambda.B for E.coli. Examples of plasmid are, for example, pBR322, pBR325, pACYC184, pUC12, pUC13, pUC18, pUC19, pUC118, pUC119, bluescript SK+, bluescript KS+, bluescript SK-, bluescript KS-, bluescript SKII+, bluescript KSII+, bluescript SKII- and bluescript KSII-. Examples of plasmids for host microorganims genus Bacillus and genus Saccharomyces are pHY300PLK and pYAC5, respectively.
Insertion method of sorbitol kinase gene into the vector is not limited, and conventional methods can be used. For example, recombinant plasmid DNA and the expression vector containing sorbitol kinase gene DNA are treated using preferable restriction enzyme to obtain DNA fragments and vector fragments containing sorbitol kinase gene. After annealing each cohesive end, each fragment is ligated by using suitable DNA ligase to obtain new expression vector.
Trunsduction of the thus constructed plasmid into E.coli and selection of transformation of desired recombinant DNA in the host microorganism can be performed by the methods described hereinbefore.
In the present invention, a transformed microorganism belonging to E.coli by the above plasmid pSK1 is designated as E.coli DH1-pSK and deposited in National Institute of Bioscience and Human-Technology, 1-3, Higashi 1 chome Tsukuba-shi Ibaraki-ken, 305 Japan, as FERM BP-4496 on Dec. 10, 1983.
Cultivation of the thus prepared transformant microorganism can be performed in a mediuim containing nutrient sources such as carbon sources and nitrogen sources and inorganic substances necessary for microbial growth. Examples of carbon sources are, for example glucose, starch, sucrose, molasses and dextrin. Examples of nitrogen sources are, for example peptone, meat extract, casein hydrolysate, corn steep liquor, nitrate and ammonium salts. Examples of inorganic substances are, for example salt containing cation such as sodium, potassium, calcium, magnesium, cobalt, zinc, manganese and iron, and anion such as chlorine, sulfate and phosphate.
Culturing condition is not limited and is made by conventional process, for example aeration stirring culture, shaking culture, rotary culture and standing culture, generally at 20.degree.-50.degree. C., preferably at 25.degree.-42.degree. C. and more preferably at 37.degree. C. for 12-48 hours.
After cultivation, cultured microbial cells were collected by centrifugation followed by destruction of the cells by enzymatic treatment, autolysis, French press and ultrasonication to prepare extracted enzyme solution. Isolation and purification of the enzyme from the extract can be made, for example, by salting out, desalting and adsorption and desorption using ion-exchange resin. Enzyme is further purified by adsorption chromatography, gel-filtration and electrophoresis.
Enzymatic activity and physico-chemical properties of sorbitol kinase were examined in the purified enzyme, and it was confirmed that the said transformant microorganism has productivity of sorbitol kinase.
Therefore, the gene DNA, which expresses sorbitol kinase used in the present invention, has a nucleotide sequence coding amino acid sequence in FIG. 9, and its nucleotide sequence is a sequence shown in FIG. 10.
The thus obtained sorbitol kinase has similar catalytic action and enzymatic properties as same as the sorbitol kinase of the strain Erwinia sp. SK-472-20 (FERM BP-4492). Namely, the enzyme catalyses a reaction generating D-sorbitol-6-phosphate and ADP from D-sorbitol and ATP. The enzyme utilizes ATP, but substantially not phosphoenolpyruvate, as a phosphate donor. In the substrate specificity, when relative activity on sorbitol is set at 100%, then the relataive activities on fructose, glucose, galactose, mannose, inositol, saccharose, maltose and lactose are 0%. Molecular weight measured by SDS acrylamide gel-chromatography is 35,000.+-.4,000. Isoelectric point is 4.80.+-.0.5.
Optimum pH is 8.5-9.5. Stable up to 60.degree. C. and pH stability is pH 6.5-10.0. The enzyme is inhibited by metal ions of copper, nickel and cobalt, and EDTA, and activated by calcium ion.
The thus obtained sorbitol kinase is useful for diagnostic enzyme for determination of serum sorbitol.
Symbols of nucleotide sequence and amino acid sequence in the specification are based on trivial abbreviation and are listed as follows. All amino acids are L-form.
DNA: deoxyribonucleic acid
A: adenine
T: thmine
G: guanine
C: cytosine
H: adenine, thymine or cytosine
N: adenine, thymine, guanine, cytosine or other base
R: adenine or guanine
Y: thyamine or cytosine
Ala: alanine
Arg: arginine
Asn: asparagine
Asp: aspartic acid
Cys: cysteine
Gln: glutamine
Glu: glutamic acid
His: histidine
Ile: isoleucine
Leu: leucine
Lys: lysine
Met: methionine
Phe: phenylalanine
Pro: proline
Ser: serine
Thr: threonine
Trp: tryptophane
Tyr: tyrosine
Val: valine
Xaa: unknown or other amino acid

BRIEF EXPLANATION OF THE DRAWINGS
FIG. 1: Optimum pH curve of sorbitol kinase of the present invention.
FIG. 2: pH stability curve of sorbitol kinase of the present invention.
FIG. 3: Optimum temperature curve of sorbitol kinase of the present invention.
FIG. 4: Heat stability curve of sorbitol kinase of the present invention.
FIG. 5: Optimum pH curve of sorbitol-6-phosphate dehydrogenase.
FIG. 6: pH stability curve of sorbitol-6-phosphate dehydrogenase.
FIG. 7: Optimum temperature curve of sorbitol-6-phosphate dehydrogenase.
FIG. 8: Heat stability curve of sorbitol-6-phosphate dehydrogenase.
FIG. 9: Amino acid sequence (SEQ ID NO: 2) of sorbitol kinase.
FIG. 10: Nucleotide sequence (SEQ ID NO: 1) of sorbitol kinase gene DNA coding amino acids of FIG. 9.
FIG. 11: Restriction map of chromosomal DNA orginated from Erwinia sp. SK-472-20 in plasmid pSK1.
FIG. 12: Schematic drawing of structure of the plasmid pSK1.
FIG. 13: Amino acid sequence (SEQ ID NO: 3) of N-terminal site of purified authentic sorbitol kinase. Underlined part corresponds to the prepared oligonucleotide probe.
FIG. 14: Amino acid sequence (SEQ ID NO: 4) of lysylendopeptidase site of sorbitol kinase.
FIG. 15: Amino acid sequence (SEQ ID NO: 5) of lysylendopeptidase site of sorbitol kinase. Xaa shows unknown amino acid.
FIG. 16: Amino acid sequence (SEQ ID NO: 6) of lysylendopeptidase site of sorbitol kinase.
FIG. 17: Nucleotide sequence of oligonucleotides used for preparation of oligonucleotide probe.
1 Nucleotide sequence (SEQ ID NO: 7) of oligonucleotide probe SK1.
2 Nucleotide sequence (SEQ ID NO: 8) of oligonucleotide probe SK2.
3 Nucleotide sequence (SEQ ID NO: 9) of oligonucleotide probe SK3. N shows inosine.
FIG. 18: Schematic drawings of construction of expression vector of sorbitol kinase gene.

EXAMPLES
Following examples illustrate details of the present invention, but are not construed as limiting.
Example 1
Erwinia sp. SK-472-20 was inoculated in five 500 ml flasks, each containing 100 ml of medium (pH 7.0) comprising yeast extract 0.5%, peptone 0.5%, starch 0.1%, K.sub.2 PO.sub.4 0.05%, KH.sub.2 PO.sub.4 0.05%, NH.sub.4 Cl 0.05% and MgSO.sub.4 0.03%, cultured at 28.degree. C. for 48 hours. The obtained seed culture liquid was added in the same medium hereinabove (200 l, pH 7.0) containing antifoam agent and cultured at 28.degree. C. for 25 hours. Cultured mass was centrifuged at 4500 rpm for 30 minutes and microbial cells 560 g was collected.
0.1% lysozyme solution 2 lit. containing 10 mM EDTA and 50 mM Tris-HCl buffer solution (pH 7.5) was added to the microbial cells and incubated at 37.degree. C. for 30 minutes to solublize the cells. Insoluble materials were removed by centrifugation at 4500 rpm for 30 minutes to obtain supernatant solution 1870 ml (41100 U). 5% protamine sulfate 18.7 ml was added to the supernatant solution to remove the precipitate by centrifugation. The thus obtained supernatant solution was dialyzed overnight against 20 mM Tris-HCl buffer solution (pH 8.5), and subjected to ion exchange chromatography of DEAE-Sepharose (2.7.times.30 cm, Pharmacia Inc.).
Elution was conducted by linear gradient elution with potassium chloride 0-1M and collected the fractions eluted with 0.2-0.3M KCl (31700 U). NaCl was dissolved at concentration of 4M in the enzyme solution, then the solution was subjected to hydrophobic chromatography using phenylSepharose (2.6.times.19.5 cm, Pharmacia Inc.). Elution was performed by 4M-0M NaCl linear gradient elution to collect the fractions of 1M-0.5M NaCl (20800 U).
The collected enzyme solution was dialyzed overnight against 10 mM Tris-HCl buffer solution (pH 8.5), and subjected to Q-Sepharose ion exchange chromatography (2.6.times.19.5 cm, Pharmacia Inc.). Elution was performed by 0-0.4M NaCl linear gradient elution to collect the fractions of 0.2-0.25M NaCl (20000 U). The thus obtained enzyme solution was dialyzed overnight against 10 mM Tris-HCl buffer solution (pH 7.5), and subjected to chromatography of hydroxyapatite (1.6.times.26. 5 cm, Pentax Inc.). Elution was performed by 0-0.3M phosphate buffer linear gradient elution to collect the fractions of 0.06-0.1M phosphate buffer (16000 U). The solution was lyophilized to obtain purified sorbitol kinase (213 U/mg, 75 mg).
Referential Example 1
Process for production of sorbitol-6-phosphatae dehydrogenase, which is used for assay of sorbitol kinase of the present invention, by Comamonas sp. SY-77-1, txonomical properties of which were described in U.S. Pat. No. 3,960,662, physico-chemical properties and assay method for enzyme activity are explained hereinbelow. The strain was deposited in National institute of Bioscience and Human-Technology, 1-3, Higashi 1 chome Tsukuba-shi Ibaraki-ken, 305 on Sep. 2, 1994 as FERMBP-4810.
Assay Method of Sorbitol-6-Phosphate Dehydrogenase.
Reaction mixture 1 ml consisting of 0.2M Tris-HCl buffer solution (pH 8.0) 0.25 ml, 0.1M sorbitol-6-phosphate 0.2 ml, 10 mM NAD 0.1 ml, 100 U/ml diaphorase (Asahi Chemical Industry Co.) 0.05 ml, 0.25% NTB (nitrotetrazolium blue) 0.1 ml, 10% Triton X-100 0.01 ml and distilled water 0.29 ml was pre-heated at 37.degree. C. for 1 minute. 0.02 ml of enzyme solution was added thereto and incubated for 10 minutes.
0.1N HCl 2 ml was added to stop the reaction, and within 5 minutes optical absorption of the reaction mixture was measured using pass length 1.0 cm cell at 550 nm (As). Optical density of the blank solution of distilled water 0.02 ml in place of the enzyme solution was measured by the same procedure (Ab). Enzyme activity was measured by the difference (As-Ab) between the optical density of the enzyme solution (As) and that of the blank (Ab). A unit of enzyme is defined as an enzyme amount which produces 1.mu. mole of reduced NAD at 37.degree. C. for 1 minute. Equation is as follows.
Enzyme activity (U/ml)=(As-Ab).times.0.795.times.enzyme dilution rate
Physico-Chemical Properties
(1) Enzyme action
Enzyme action using substrate sorbitol-6-phosphate is shwon as follows.
Sorbitol-6-phosphate+NAD=fructose-6-phosphate+NADH+H.sup.+
(2) Substrate specificity
Enzyme shows substrate specificity for sorbitol-6-phosphate. Specific activities on various substrates are shown in Table 3.
TABLE 3______________________________________Substrate Relative activity (5)______________________________________sorbitol-6-phosphate 100glucose-1-phosphate 0glucose-6-phosphate 0galactose-1-phosphate 0galactose-6-phosphate 0fructose-1,6-diphosphate 0glucose 0fructose 0galactose 0mannitol 0lactose 0mannose 0saccharose 0treharose 0______________________________________
(3) Km
Km for sorbitol-6-phosphate 2.0.+-.0.5 (mM), for NAD 0.13.+-.0.05 mM and for thio NAD 0.14.+-.0.05 mM.
(4) Isoelectric point
Isoelectric point of the enzyme measured by electrophoresis using carrier ampholite, pH 3.5-10.0, is 4.8.+-.0.2.
(5) Molecular weight
Molecular weight of the enzyme measured by gel-filtration using TSK-G3000SW (0.75.times.60 cm. Toso Corp.) is 70,000.+-.5,000.
(6) Optimum pH
Optimum pH of the ezmzyme was mesured according to the assay method hereinbefore. Results are shown in FIG. 5. In FIG. 5, activity at pH 6.0-6.5 was measured in 100 mM acetate buffer solution (-.largecircle.-); 100 mM phosphate buffer solution for pH 6.5-8.0 (-.quadrature.-); 100 mM Tris-HCl buffer solution for pH 7.5-9.0 (-.DELTA.-) and 100 mM glycine-sodium hydroxide for pH 9.0-10.0 (-.circle-solid.-). Optimum pH is 8-8.5.
(7) pH stability
Sorbitol-6-phosphate dehydorgenase 1 U/ml was treated in various buffer solution at 37.degree. C. for 60 minutes and remaining activity was measured according to the assay method hereinbefore. Results are shown in FIG. 6. In FIG. 6; 100 mM acetate buffer for pH 5.0-6.5 (-.largecircle.-); 100 mM phosphate buffer solution for pH 6.5-8.0 (-.quadrature.-); 100 mM Tris-HCl buffer solution for pH 7.5-9.0 (-.DELTA.-) and 100 mM glycine-sodium hydroxide for pH 9.0-11.0 (-.circle-solid.-). Most preferred stability is observed at pH 8-11.
(8) Optimum temperature
Enzyme activity was measured according to the assay method hereinbefore at 37.degree. C.-60.degree. C. Result is shown in FIG. 7. Optimum temperature is approximately at 50.degree. C.
(9) Heat stability
100 mM Tris-HCl buffer solution (pH 8.5) of sorbitol-6-phosphate dehydrogenase 1 U/ml was heated for 10 minutes and remaining activity was measured according to the assay method hereinbefore. Results are shown in FIG. 8. Enzyme activity is stable at least up to 37.degree. C.
(10) Effect of metal ion
Effect of 1 mM metal ions on sorbitol-6-phosphate dehydrogenase activity is shown in Table 4. Strong inhibition was observed in copper ion and lead ion.
TABLE 4______________________________________Metal ion Relateive activity______________________________________None 100LiCl 100NaCl 100KCl 100CsCl 100CuCl.sub.2 0BaCl.sub.2 32ZnCl.sub.2 6PbCl.sub.2 2NiCl.sub.2 100CoCl.sub.2 100MnCl.sub.2 40CaCl.sub.2 100MgCl.sub.2 100______________________________________
Process for production of sorbitol-6-phosphate dehydrogenase are illustrated in detail.
Culture of Comamonas sp. SY-77-1
Each 100 ml of medium (pH 7.0) containing sorbitol 2.0% and brain heart infusion 2.0% in twenty 500 ml flask was sterilized at 120.degree. C. for 20 minutes. A loopful culture of Comamonas sp. SY-77-1 was inoculated thereto and shake cultured at 28.degree. C., 120 rpm, for 20 hours to obtain culture liquid 1.9 lit., enzyme activity 2.7 U/ml.
Isolation and Purification of Enzyme
The cultured liquid 1.9 lit. was centrifuged and the obtained microbial cells were washed with 20 mM Tris-HCl buffer solution (pH 8.5) 2 lit. Washed cells were suspended in the same buffer 50 ml and sonicated at 180 W for 30 minutes using ultrasonicator (INSONATOR 201M, Kubota Corp.) to obtain the lyzate. The lyzate was centrifuged at 12000 rpm for 20 minutes to obtain supernatant solution 42 ml (enzyme activity 105 U/ml, 4200 U). The supernatant solution was dialyzed using dialyzing tube against 20 mM Tris-HCl buffer solution (pH 8.0) 5 lit. at 5.degree. C. for overnight to obtain crude enzyme solution 51 ml (enzyme activity 85 U/ml, 4340 U).
Enzyme solution was passed through a column of DEAE-Sepharose CL-6B (Pharmacia Inc.) 100 ml (2.6.times.19 cm) bufferized with 20 mM Tris-HCl buffer solution (pH 8.0). The column was washed with 20 mM Tris-HCl buffer solution (pH 8.0) 1 lit. containing 0.2M KCl then eluted with 20 mM Tris-HCl buffer solution (pH 8.0) 1 lit. containing 0.3M KCl to obtain enzyme solution 250 ml (enzyme activity 13 U/ml. 3250 U). NaCl was dissolved in the enzyme solution up to 3M. The enzyme solution was passed through a column of Phenyl-Sepharose (Pharmacia Inc.) 50 ml (1.5.times.28 cm) bufferized with 20 mM Tris-HCl buffer solution (pH 8.0) containing 3M NaCl.
Elution was performed by 3M-0M NaCl linear gradient. Fractions eluted at 1M-0M NaCl (enzyme activity 35 U/ml, 2450 U) were collected. Bovine serum albumin 100 mg was dissolved in the enzyme solution. The solution was lyophilized to obtain enzyme powder 68 mg (enzyme activity 33 U/ml).
Referential Example 2
Isolation of Chromosomal DNA
Erwinia sp. SK-472-20 (FERM BP-4492) was shake cultured in a medium (yeast extract 0.5%. peptone 0.5%, K.sub.2 HPO.sub.4 0.05%, KH.sub.2 PO.sub.4 0.05%. NH.sub.4 Cl 0.05%, and MgSO.sub.4.7H.sub.2 O 0.03%, pH 7.0) 100 ml at 37.degree. C. for 40 hours. The cultured mass was centrifuged by high speed freezing centrifuge (TomiiCX-250) at 6500 rpm (7660 G) for 10 minutes to collect microbial cells.
The cells were suspended in a solution 20 ml containing of 50 mM Tris-HCl buffer solution (pH 8.0), 50 mM EDTA (pH 8.0) and 15% sucrose. Lysozime (Seikagaku Kogyo K.K.) was added up to final concentration 2 mg/ml and treated at 37.degree. C. for 10 minutes to lyzate cell wall.
10% sodium lauryl sulfate (SIGMA Corp.) solution 1 ml was added to the suspension and treated at 37.degree. C. for 5 minutes. Chloroform/phenol (1:1) mixture 21 ml was added with stirring and the mixture was centrifuged at 10000 rpm (12080 G) for 10 minutes to collect water layer. Twice volume of ethanol was added gently to the water phase, slowly stirred using glass rodto twine DNA in the glass rod. DNA was dissolved in the solution 20 ml consisting of 10 mM Tris-HCl buffer solution (pH 8.0) and 1 mM EDTA. RNase (Pharmacia Inc.) was added up to the final concentration at 10 .mu.g/ml and treated at 37.degree. C. for 30 minutes. Equal volume of mixture of phenol/chloroform (1/1) was added and treated by the same way hereinabove to isolated water phase.
Twice volume of ethanol was added to the water phase and isolated the DNA by the same procedures hereinabove, then DNA was dissolved in a solution 2 ml consisting of 10 mM Tris-HCl buffer solution (pH 8.0) and 1 mM EDTA.
Referential Example 3
Preparation of Gene Library of Erwinia sp. SK-472-20
Chromosome of Erwinia sp. SK-472-20 5 .mu.g obtained in referential example 2 was digested using restriction enzyme HindIII (Takara Shuzo Co.) 10 units in a solution containing 10 mM Tris-acetate buffer (pH 7.5), 50 mM NaCl, 10 mM MgCl.sub.2 and 1 mM DTT at 37.degree. C. for 2 hours.
Vector plasmid PUC118 (Takara Shuzo Co.) 3 .mu.g in the other vessel was split by HindIII (Takara Shuzo Co.) 10 units in a solution containing 10 mM Tris-acetate buffer. (pH 7.5), 50 mM NaCl, 10 mM MgCl.sub.2 and 1 mM DTT at 37.degree. C. for 2 hours, and alkaline phosphatase (Takara Shuzo Co.) 1 unit was added thereto for dephosphorylation of 5'-terminal, then treated at 65.degree. C. for 2 hours.
The thus obtained two DNA solutions hereinabove were mixed. Equal volume of phenol/chloroform (1/1) mixture was added to the mixture and centrifuged to separate water layer. A 1/10 volume of 3M sodiuim acetate solution and twice volume of ethanol were added to the water layer and centrifuged to collect DNA which was dried up in vacuo.
The obtained DNA was dissolved in a solution containing 10 mM Tris-HCl buffer (pH 8.0 and 1 mM EDTA solution and was ligated in the presence of 66 mM Tris-HCl buffer (pH 7.6), 6.6 mM MgCl.sub.2, 10 mM DTT and 660 .mu.M ATP (Boehringer Mannheim GmbH) using T4DNA ligase (Takara Shuzo Co.) 300 units at 4.degree. C. for 16 hours.
The ligated DNA was transformed into competent cell �A. Nishimura et al. Nucleic Acid Res. 18, 6169 (1990)! of E.coli DH1 (ATCC 33849) �F-, recA1, endA1, gyrA96, thi-1, hsdR17 (fk-, mk+), supE44, relA1, .lambda.-!�Molecular Cloning: Cold Spring Harbor, 504-506 (1982)!. The transformed cells were incubated in BHI agar medium containing ampicillin 50 .mu.g/ml at 37.degree. C. for overnight to obtain about 10,000 transformants which were designated as gene library of Erwinia sp. SK-472-20.
Example 2
Preparation of Radioactive Oligonucleotide Probe
N-terminal amino acid sequence of purified authentic sample of sorbitol kinase is shwon in FIG. 13 (SEQ ID NO. 2). Amino acid sequences of lysylendopeptidase treated fragments are shown in FIG. 14 (SEQ ID NO. 3), FIG. 15 (SEQ ID NO. 4) and FIG. 16 (SEQ ID NO. 5).
Nucleotide sequence from 5'-terminal of the gene was estimated. Since estimated nucleotide sequence may be thought to be various combinations, oligonucleotides of small number of combinations were designed and experiments were conducted. The oligonucleotides were prepared by a method of R. L. Lessinger et al.(J. Am. Chem. Soc., 98: 365 5) using DNA synthesizer �Cyclon (Biosearch Inc.)!. In the N-teminal amino acid sequence in FIG. 13, synthetic DNA corresponding to amino acid sequence from amino acid residue No. 34 Asp to No. 39 Thr was prepared. 32 combinations will exist in case of 17 mer. 17 mer oligonucleotide probe SK1 shown in FIG. 17 1, SEQ. ID NO. 6 which is complementary to mRNA estimated by amino acid sequence, was prepared.
Isotope .sup.32 P was incorporated into the thus obtained oligonucleotide 5 pmol in the presence of T4 polynucleotide kinase buffer �50 mM Tris-HCl buffer (pH 8.0), 10 mM MgCl.sub.2, 4 mM DTT, 0.1 mM EDTA and 0.1 mM spermidine! and 370 kBq �.gamma.-.sup.32 P! ATP (Amersham Inc.) by T4 polynucleotide kinase 8.5 units at 37.degree. C. for 30 minutes to prepare radioactive oligonucleotide probe. However, although cloning of sorbitol kinase gene was attempted by using the radioactive oligonucleotide probe under various conditions, required gene could not be obtained.
In the N-teminal amino acid sequence in FIG. 13, synthetic DNA corresponding to amino acid sequence from amino acid residue No. 34 Asp to No. 40 Ile was prepared. 128 combinations will exist in case of 20 mer. Considering the frequency of use of codon in Erwinia gene �K. Wada et al. (Nucleic Acids Research, 20: 2114, 1992)!, combination of codon for amino acid residue No. 39 Thr is selected to ACC and ACG. 20 mer oligonucleotide probe SK1 shown in FIG. 17 2, SEQ. ID NO. 7 which is complementary to mRNA estimated by amino acid sequence, was prepared.
Isotope .sup.32 P was incorporated by the same way as described hereinabove to prepare radioactive oligonucleotide probe. However, although cloning of sorbitol kinase gene was attempted by using the radioactive oligonucleotide probe under various conditions, required gene could not be obtained. The reason was confirmed later that the selected codon for Thr in that sequence was very rare codon of ACT. This means that selection of the present gene is quite difficult.
In the N-teminal amino acid sequence underlined in FIG. 13, synthetic DNA corresponding to amino acid sequence from amino acid residue No. 34 Asp to No. 44 Ala was prepared. 9216 combinations will exist in case of 32 mer. Consequently, in the six amino acids, inosine was used in the third letter of codon and the combination was restricted within 16 combinations. 32 mer oligonucleotide probe SK3 shown in FIG. 17 3, SEQ. ID NO. 8 which is complementary to mRNA estimated by amino acid sequence, was prepared.
Isotope .sup.32 P was incorporated by the same way as described hereinabove to prepare radioactive oligonucleotide probe.
Example 3
Screening for Sorbitol Kinase Gene Containing DNA
Nylon membrane filter (Magnagraphnylon, Microseparation Inc.) was overlayered on the ampicillin resistant colonies of the Erwinia sp. SK-472-20 gene DNA on the agar plate medium to transfer a part of the colonies on the filter. The filter was soaked in alkaline denaturant solution (0.5N--NaOH containing 1.5M NaCl) for 5 minutes, was further soaked in the neutralization solution �a mixture of 0.5M Tris-HCl buffer (pH 7.0) and 3M NaCl! for 5 minutes and dried.
The filter was heated at 80.degree. C. for 2 hours to bind the plasmid DNA in the bacterial cells on the filter. The filter was further soaked in hybridization solution (NaCl 43.8 g/l, trisodiuim citrate 22.1 g/l, 50 mM triphosphate (pH 6.5), sodium lauryl sulfate 1 g/l, ficol 1 g/l, polyvinyl pyrrolidone 1 g/l, BSA 1 g/l, salmon sperm DNA 250 mg/l and formamide 200 ml/l) and conducted hybridization at 42.degree. C. for 1 hour. The filter was again soaked into the new hybridization solution, and the radioactive oligonucleotide probe shown in FIG. 17 3 obtained in the example 1 was added and was subjected to hybridization at 42.degree. C. for one day.
After hybridization was completed, the filter was washed three times with washing solution (NaCl 4.38 g/l, trisodium citrate 2.21 g/l and sodium lauryl sulfate 1 g/l), then the filter was soaked in the washing solution at 42.degree. C. for 10 minutes to remove excess probes. The filter was dried, overlayered on X-ray film (Fuji Photo Film Co., HR-H) and subjected to autoradiography in the dark at -80.degree. C. for 24 hours.
The film was developed and the colonies showing positive signals were found. Restriction map of the DNA inserted in the plasmid in recombinant E.Coli which forms said colonies is shown in FIG. 11.
The said colony has been designated as E.coli DH1-pSK1 (FERM BP-4496) which is a transformant containing DNA coding sorbitol kinase. The plasmid in the said transformant E.coli DH1-pSK1 was designated as pSK1. Plasmid construction strategies for pSK1 is shown in FIG. 18.
Example 4
Determination of Nucleotide Sequence of DNA Coding Sorbitol Kinase
The PSK1DNA was extracted from E.coli DH1 harboring plasmid pSK1 by a method of T. Malniatis et al. �"Molecular Cloning: Cold Spring Harbor", p. 86-94 (1982)!. Schematic drawing of this plasmid is shown in FIG. 12. A sequence originated from Erwinia sp. SK-472-20 chromosome was determined by dideoxy chain termination method (Science, 214: 1205-1210, 1981) to confirm whole DNA coding sorbitol kinase. The total nucleotide sequence thereof was determined and was confirmed at least to contain the sequence shown in FIG. 10.
N-terminal amino acid sequence of sorbitol kinase and lysylendopeptidase treated fragment were identified in the same frame.
Amino acid sequence of sorbitol kinase shown in FIG. 9 as well as its activity was also confirmed.
Example 5
Expression of Sorbitol Kinase Activity in E.coli
The transformant E.coli DH1-pSK harboring sorbitol kinase coding DNA obtained in the example 3 was cultured in BHI medium containing ampicillin 50 .mu.g/ml at 37.degree. C. for 24 hours, and cultured mass was centrifuged at 15,000 rpm for 1 minute to collect the precipitate. Equal amount of 10M Tris-HCl buffer (pH 8.0) was added to the precipitate and the mixture was sonicated. Activity of sorbitol kinase was assayed by the following methods.
A reaction mixture 1 ml consisting of 100 mM Tris-HCl buffer solution (pH 8.5), 2 mM ATP, 2 mM MgCl.sub.2, 5 unit/ml sorbitol-6-phosphatedehydrogenase (refer to referential example 3), 1 mM NAD, 5 units/ml diaphorase (Asahi Chem. Ind. Co.), 0.025% nitrotetrazolium blue, 100 mMD-sorbitol and 0.1% Triton X-100 was incubated with the aliqluot diluted sonicated microbial cells 20 .mu.l at 37.degree. C. for 10 minutes. Reaction was stopped by adding 0.1N HCl 2.0 ml and the optical absorption at 550 nm was measured for determination of sorbitol kinase activity. For control study, sonicated E.coli DH1 harboring pUC118 was treated by the same way as above to determine activity of sorbitol kinase. Results showed very surprisingly that activity of transformant microbial cells harboring plasmid pSK1 was 200 U/ml, but the cells harboring plasmid pUC 118 was 0 U/ml. Accordingly, the transformant having sorbitol kinase activity was confirmed. Isolated and purified sorbitol kinase showed identical molecular weight and isoelectric point as of the enzyme of Erwinia sp. SK-472-20, consequently the physico-chemical properties of expressed protein was confirmed.
EFFECT OF THE INVENTION
The present invention provides sorbitol kinase and novel process for production of sorbitol kinase by microorganism belonging to genus Erwinia. The invention also provides enzyme for assaying sorbitol using the present enzyme. Further according to the present invention, a gene DNA expressing sorbitol kinase is screened from chromosomal DNA library originated from Erwinia sp. SK-472-20; a recombinant plasmid of expression vector constructed by using the said DNA was, for example transformed into a microorganism belonging to E.coli; and the thus obtained transformant microorganism produces sorbitol kinase having enzymatic action utilizing mainly ATP, but not substantially phosphoenolpyruvate, as the phosphate donor.
Furthermore according to the present invention, whole amino acid sequence of sorbitol kinase and nucleotide sequence of gene DNA coding the said amino acids. Protein engineering of the said enzyme such as converting the substrate and coenzyme specificities or improving heat resistance, can be attempted.
__________________________________________________________________________SEQUENCE LISTING(1) GENERAL INFORMATION:(iii) NUMBER OF SEQUENCES: 10(2) INFORMATION FOR SEQ ID NO:1:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 1075 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: double(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(ix) FEATURE:(A) NAME/KEY: CDS(B) LOCATION: 31..972(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:GTTGATAATCAAAATAATGAGGAGTGTCTTATGCGTATTGGGATTGATTTGGGC54MetArgIleGlyIleAspLeuGly15GGCACTAAAACAGAAGTCATCGCACTGAGCGAGCAGGGGGAGCAACTG102GlyThrLysThrGluValIleAlaLeuSerGluGlnGlyGluGlnLeu101520TTCCGCCACCGTCTGCCTACGCCGCGCGATGATTATCACCAGACTATC150PheArgHisArgLeuProThrProArgAspAspTyrHisGlnThrIle25303540GAGACGATTGCCCGGCTGGTCGACATGGCTGAGCAGGCGACAGGGCAG198GluThrIleAlaArgLeuValAspMetAlaGluGlnAlaThrGlyGln455055ACCGGCACCGTTGGGATGGGGATCCCGGGGTCAATCTCGCCCTATACC246ThrGlyThrValGlyMetGlyIleProGlySerIleSerProTyrThr606570GGGGTGGTTAAAAACGCCAACTCCACCTGGCTCAACGGTCAGCCTTTT294GlyValValLysAsnAlaAsnSerThrTrpLeuAsnGlyGlnProPhe758085GATAAAGATTTAAGTCAGCGCCTGAACCGGGAAGTGCGTCTGGCAAAT342AspLysAspLeuSerGlnArgLeuAsnArgGluValArgLeuAlaAsn9095100GACGCCAACTGTCTGGCCGTCTCCGAAGCCATTGACGGTGCCGCCGCA390AspAlaAsnCysLeuAlaValSerGluAlaIleAspGlyAlaAlaAla105110115120GGGGCCCAGACCGTTTTTGCGGTCATTATCGGGACCGGCTGTGGCGCA438GlyAlaGlnThrValPheAlaValIleIleGlyThrGlyCysGlyAla125130135GGCGTGGCCCTGGGCGGGCGTGCCCATATTGGCGGCAACGGTACGGCG486GlyValAlaLeuGlyGlyArgAlaHisIleGlyGlyAsnGlyThrAla140145150GGCGAGTGGGGACATAACCCCTTGCCGTGGATGGATGAAGATGAACTT534GlyGluTrpGlyHisAsnProLeuProTrpMetAspGluAspGluLeu155160165AAATACCGCGCCGAGGTGCCGTGCTATTGCGGCAAGCAGGGCTGTATT582LysTyrArgAlaGluValProCysTyrCysGlyLysGlnGlyCysIle170175180GAGACGTTTATCTCCGGCACCGGTTTTGCCACCGATTACCACCGCCTG630GluThrPheIleSerGlyThrGlyPheAlaThrAspTyrHisArgLeu185190195200AGTGGCCAGCCACTCAAGGGGAACGAGATTATGCGCCGGGTCGGGGAA678SerGlyGlnProLeuLysGlyAsnGluIleMetArgArgValGlyGlu205210215CACGATCCGGTGGCTGAGCTGGCTCTCAGCCGCTATGAAATGCGGCTG726HisAspProValAlaGluLeuAlaLeuSerArgTyrGluMetArgLeu220225230GCGAAATCCCTGGCGCACGTGGTGAATATCCTTGACCCTGACGTGATT774AlaLysSerLeuAlaHisValValAsnIleLeuAspProAspValIle235240245GTGCTCGGCGGCGGGATGAGCAACGTCGACCGTTTATATGCCACGGTA822ValLeuGlyGlyGlyMetSerAsnValAspArgLeuTyrAlaThrVal250255260CCGAATCTGGTGAAGCAGTGGGTCTTCGGGGGTGAGTGTGAAACCCCG870ProAsnLeuValLysGlnTrpValPheGlyGlyGluCysGluThrPro265270275280ATCCGAAAGCGGTGCACGGGGACTCCAGCGGCGTGCGCGGCGCCGCGT918IleArgLysArgCysThrGlyThrProAlaAlaCysAlaAlaProArg285290295GGCTCTGGCCGCTATAGCCATTCTCCCTCTCCCTACGTGAGAGGGGCG966GlySerGlyArgTyrSerHisSerProSerProTyrValArgGlyAla300305310GGATGAGGGTGCCCTCATGCAGGGCACCCTCACTCCACCGCAAACACCTTATCCAG1022Gly*CTTGCTATACCCCAGCCCGTTAATCTTCTTCACTTTGATCTGCACCGGGATCC1075(2) INFORMATION FOR SEQ ID NO:2:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 313 amino acids(B) TYPE: amino acid(D) TOPOLOGY: linear(ii) MOLECULE TYPE: protein(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:MetArgIleGlyIleAspLeuGlyGlyThrLysThrGluValIleAla151015LeuSerGluGlnGlyGluGlnLeuPheArgHisArgLeuProThrPro202530ArgAspAspTyrHisGlnThrIleGluThrIleAlaArgLeuValAsp354045MetAlaGluGlnAlaThrGlyGlnThrGlyThrValGlyMetGlyIle505560ProGlySerIleSerProTyrThrGlyValValLysAsnAlaAsnSer65707580ThrTrpLeuAsnGlyGlnProPheAspLysAspLeuSerGlnArgLeu859095AsnArgGluValArgLeuAlaAsnAspAlaAsnCysLeuAlaValSer100105110GluAlaIleAspGlyAlaAlaAlaGlyAlaGlnThrValPheAlaVal115120125IleIleGlyThrGlyCysGlyAlaGlyValAlaLeuGlyGlyArgAla130135140HisIleGlyGlyAsnGlyThrAlaGlyGluTrpGlyHisAsnProLeu145150155160ProTrpMetAspGluAspGluLeuLysTyrArgAlaGluValProCys165170175TyrCysGlyLysGlnGlyCysIleGluThrPheIleSerGlyThrGly180185190PheAlaThrAspTyrHisArgLeuSerGlyGlnProLeuLysGlyAsn195200205GluIleMetArgArgValGlyGluHisAspProValAlaGluLeuAla210215220LeuSerArgTyrGluMetArgLeuAlaLysSerLeuAlaHisValVal225230235240AsnIleLeuAspProAspValIleValLeuGlyGlyGlyMetSerAsn245250255ValAspArgLeuTyrAlaThrValProAsnLeuValLysGlnTrpVal260265270PheGlyGlyGluCysGluThrProIleArgLysArgCysThrGlyThr275280285ProAlaAlaCysAlaAlaProArgGlySerGlyArgTyrSerHisSer290295300ProSerProTyrValArgGlyAlaGly305310(2) INFORMATION FOR SEQ ID NO:3:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 52 amino acids(B) TYPE: amino acid(C) STRANDEDNESS:(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:MetArgIleGlyIleAspLeuGlyGlyThrLysThrGluValIleAla151015LeuSerGluGlnGlyGluGlnLeuPheArgHisArgLeuProThrPro202530ArgAspAspTyrHisGlnThrIleGluThrIleAlaArgLeuValAsp354045MetAlaGluGln50(2) INFORMATION FOR SEQ ID NO:4:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 14 amino acids(B) TYPE: amino acid(C) STRANDEDNESS:(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:AsnAlaAsnSerThrTrpLeuAsnGlyGlnProPheAspLys1510(2) INFORMATION FOR SEQ ID NO:5:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 14 amino acids(B) TYPE: amino acid(C) STRANDEDNESS:(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:XaaTrpValPheGlyGlyGluXaaGluThrProIleArgLys1510(2) INFORMATION FOR SEQ ID NO:6:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 32 amino acids(B) TYPE: amino acid(C) STRANDEDNESS:(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:TyrArgAlaGluValProCysTyrCysGlyLysGlnGlyCysIleGlu151015ThrPheIleSerGlyThrGlyPheAlaThrAspTyrHisArgLeuSer202530(2) INFORMATION FOR SEQ ID NO:7:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 17 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: other nucleic acid(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:GAYGAYTAYCAYCARAC17(2) INFORMATION FOR SEQ ID NO:8:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 20 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: other nucleic acid(xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:GAYGAYTAYCAYCARACSAT20(2) INFORMATION FOR SEQ ID NO:9:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 32 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: other nucleic acid(xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:GAYGAYTAYCAYCANACNATNGANACNATNGC32(2) INFORMATION FOR SEQ ID NO:10:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 20 amino acids(B) TYPE: amino acid(C) STRANDEDNESS:(D) TOPOLOGY: linear(ii) MOLECULE TYPE: peptide(xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:MetArgIleGlyIleAspLeuGlyGlyThrLysThrGluValIleAla151015LeuSerGluGln20__________________________________________________________________________

Number	Date	Country	Kind
6-243539	Oct 1994	JPX
6-247419	Oct 1994	JPX

Sorbitol kinase, process for producing the same, and substantially pure microorganism

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

Priority Claims (2)

PCT Information

Non-Patent Literature Citations (5)

Entry
Neubaur et al. (1967) Z. Physiol. Chem., 348(7), "Decomposition of Sorbitol by Bacteria in Rat Feces". pp. 871-876.
Srivastava et al. (1982) Biochim. Biophys. Acta, 717(2), "Formation of Sorbitol 6-phosphate by Bovine and Human Lens Aldose Reductase, Sorbitol Dehydrogenase and Sorbitol Kinase", pp. 210-214.
T. Yaginuma, et al., "Does an enzyme activity capable of phosphorylating sorbitol control utilization of sorbitol at the termination of diapause in eggs of the silkworm, Bombyx Mori?", 1991, pp. 135-141, Comp. Biochem. Physial, vol. 98B, No. 1.
S. K. Srivastava, et al., "Formation of sorbitol 6-phosphata by bovine and human lens aldose reductase, sorbitol dehydrogenase and sorbitol kinase", 1982, pp. 210-213, Biochimica et Biophysica Acta, 717.
N. E. Kelker, et al., "Sorbitol Metabolism in aerobacter aerogenes", Jan., 1971, pp. 160-164, Journal of Bacteriology.